114 related articles for article (PubMed ID: 36815648)
1.
Bhattacharyya S
Pharm Nanotechnol; 2023 Jun; 11(3):294-302. PubMed ID: 36815648
[TBL] [Abstract][Full Text] [Related]
2. Experimental Design Supported Liposomal Aztreonam Delivery:
Bhattacharyya S; Sudheer P; Das K; Ray S
Adv Pharm Bull; 2021 Sep; 11(4):651-662. PubMed ID: 34888212
[No Abstract] [Full Text] [Related]
3. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design.
Kaur P; Garg T; Rath G; Murthy RS; Goyal AK
Drug Deliv; 2016 Jul; 23(6):1912-25. PubMed ID: 25544602
[TBL] [Abstract][Full Text] [Related]
4. Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lung fibroblasts.
Marianecci C; Paolino D; Celia C; Fresta M; Carafa M; Alhaique F
J Control Release; 2010 Oct; 147(1):127-35. PubMed ID: 20603167
[TBL] [Abstract][Full Text] [Related]
5. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
[TBL] [Abstract][Full Text] [Related]
6. Characterization and skin permeation of ketoprofen-loaded vesicular systems.
Uchino T; Lefeber F; Gooris G; Bouwstra J
Eur J Pharm Biopharm; 2014 Feb; 86(2):156-66. PubMed ID: 23500115
[TBL] [Abstract][Full Text] [Related]
7. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy:
Abd-Elhakeem E; El-Nabarawi M; Shamma R
Drug Deliv; 2021 Dec; 28(1):642-654. PubMed ID: 33787445
[TBL] [Abstract][Full Text] [Related]
8. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
Shaikh KS; Chellampillai B; Pawar AP
Drug Dev Ind Pharm; 2010 Aug; 36(8):946-53. PubMed ID: 20196642
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and drug delivery application of Dapsone based double tailed biocompatible nonionic surfactant.
Gul J; Ullah S; Ali I; Rao K; Iqbal KM; Jabri T; Perveen S; Rashid A; Shah MR
Chem Phys Lipids; 2021 Sep; 239():105115. PubMed ID: 34252425
[TBL] [Abstract][Full Text] [Related]
10. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.
Martins S; Tho I; Souto E; Ferreira D; Brandl M
Eur J Pharm Sci; 2012 Apr; 45(5):613-23. PubMed ID: 22245538
[TBL] [Abstract][Full Text] [Related]
11. Surfactant Effects on Lipid-Based Vesicles Properties.
Bnyan R; Khan I; Ehtezazi T; Saleem I; Gordon S; O'Neill F; Roberts M
J Pharm Sci; 2018 May; 107(5):1237-1246. PubMed ID: 29336980
[TBL] [Abstract][Full Text] [Related]
12. The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic.
Singh S; Vardhan H; Kotla NG; Maddiboyina B; Sharma D; Webster TJ
Int J Nanomedicine; 2016; 11():1475-82. PubMed ID: 27114707
[TBL] [Abstract][Full Text] [Related]
13. Lipid vesicles and other colloids as drug carriers on the skin.
Cevc G
Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded micro or nano transfersome formulation into novel tablets for pulmonary drug delivery via nebulization.
Khan I; Apostolou M; Bnyan R; Houacine C; Elhissi A; Yousaf SS
Int J Pharm; 2020 Feb; 575():118919. PubMed ID: 31816351
[TBL] [Abstract][Full Text] [Related]
15. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
[TBL] [Abstract][Full Text] [Related]
16. Acyclovir Solid Lipid Nanoparticles for Skin Drug Delivery: Fabrication, Characterization and In vitro Study.
Bhupinder K; Newton MJ
Recent Pat Drug Deliv Formul; 2017; 11(2):132-146. PubMed ID: 28124592
[TBL] [Abstract][Full Text] [Related]
17. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
Kaur IP; Rana C; Singh M; Bhushan S; Singh H; Kakkar S
J Ocul Pharmacol Ther; 2012 Oct; 28(5):484-96. PubMed ID: 22694593
[TBL] [Abstract][Full Text] [Related]
20. [Preparation and in vitro characterization of apigemin-loaded nanostructured lipid carriers].
Zhai YJ; Guo CY; Hou JN; Zhang WD; Zhai GX
Zhong Yao Cai; 2011 Jun; 34(6):962-5. PubMed ID: 22017012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
